Hashimoto's encephalitis as a differential diagnosis of Creutzfeldt-Jakob disease

Journal of Neurology Neurosurgery and Psychiatry

Volumn 66, Issue 2, 1999, Pages 172-176

  Seipelt, M ^a   Zerr, I ^a   Nau, R ^a   Mollenhauer, B ^a   Kropp, S ^a   Steinhoff, B J ^a   Wilhelm Gossling C ^b   Bamberg, C ^c   Janzen, R W C ^c   Berlit, P ^d   Manz, F ^e   Felgenhauer, K ^a   Poser, S ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b HANNOVER MEDICAL SCHOOL   (Germany)

^c KRANKENHAUS NORDWEST   (Germany)

^d ALFRIED KRUPP KRANKENHAUS   (Germany)

^e KLINIKUM LIPPE DETMOLD   (Germany)

Author keywords

Creutzfeldt Jakob disease; Encephalopathy; Hashimoto's encephalitis; Hashimoto's thyroiditis

Indexed keywords

THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE;

ADULT; AGED; ARTICLE; CEREBROSPINAL FLUID; CLINICAL ARTICLE; CREUTZFELDT JAKOB DISEASE; DIFFERENTIAL DIAGNOSIS; ENCEPHALITIS; FEMALE; HASHIMOTO DISEASE; HUMAN; LEUKOCYTE COUNT; MALE; PRIORITY JOURNAL;

EID: 0032934808     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.66.2.172     Document Type: Article

References (35)

1. Poser S, Zerr I, Schulz-Schaeffer WJ, et al. Die Creutzfeldt-Jakob-Krankheit. Eine Sphinx der heutigen Neurobiologie. Dtsch Med Wochenschr 1997;122:1099-105.
2. Brain L, Jellinek EH, Ball K. Hashimoto's disease and encephalopathy. Lancet 1966;ii:512-4.
3. Brown P, Gibbs CJ, Rodgers-Johnson P, et al. Human spongiform encephalopathy: the National Institutes of Health series of 300 cases of experimentally transmitted disease. Ann Neurol 1994;35:513-29.
4. Steinhoff BJ, Racker S, Herrendorf G, et al. Accuracy and reliability of periodic sharp wave complexes in Creutzfeldt-Jakob disease. Arch Neurol 1996;53:162-6.
5. Otto M, Stein H, Szudra A, et al. S-100 protein concentration in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurol 1997;244:566-70.
6. Otto M, Wiltfang J, Tumani H, et al. Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Neurosci Lett 1997;225:210-2.
7. Hsich G, Kenney K, Gibbs CJ, et al. The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies [comments]. N Engl J Med 1996;335:924-30.
8. Zerr I, Bodemer M, Gefeller O, et al. Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob Disease. Ann Neurol 1998;43:32-40.
9. Zerr I, Bodemer M, Racker S, et al. Cerebrospinal fluid concentration of neuron-specific enolase in diagnosis of Creutzfeldt-Jakob disease. Lancet 1995;345:1609-10.
10. Kruse H. Thyrotropin-releasing hormone: interaction with chlorpromazine in mice, rats, and rabbits. J Pharmacol 1975;6:249-68.
11. Brown M, Vale W. Central nervous system effects of hypothalamic peptides. Endocrinology 1975;96:1333-6.
12. Thrush DC, Boddie HG. Episodic encephalopathy associated with thyroid disorders. J Neurol Neurosurg Psychiatry 1974;37:696-700.
13. Jellinek EH, Ball K. Letter: Hashimoto's disease, encephalopathy, and splenic atrophy. Lancet 1976;i:1248.
14. Latinville D, Bernardi O, Cougoule JP, et al. Hashimoto's thyroiditis and myoclonic encephalopathy. Pathogenic hypothesis. Rev Neurol (Paris) 1985;141:55-8.
15. Shein M, Apter A, Dickerman Z, et al. Encephalopathy in compensated Hashimoto thyroiditis: a clinical expression of autoimmune cerebral vasculitis. Brain Dev 1986;8:60-4.
16. Shaw PJ, Walls TJ, Newman PK, et al. Hashimoto's encephalopathy: a steroid-responsive disorder associated with high anti-thyroid antibody titers; report of 5 cases. Neurology 1991;41:228-33.
17. Ghawche F, Bordet R, Destee A. Hashimoto's encephalopathy: toxic or autoimmune mechanism? Rev Neurol (Paris) 1992;148:371-3.
18. Takahashi S, Mitamura R, Itoh Y, et al. Hashimoto encephalopathy: etiologic considerations. Pediatr Neurol 1994;11:328-31.
19. Henchey R, Cibula J, Helveston W, et al. Electroencephalographic findings in Hashimoto's encephalopathy. Neurology 1995;45:977-81.
20. Ishii K, Hayashi A, Tamaoka A, et al. Case report: thyrotropin-releasing hormone-induced myoclonus and tremor in a patient with Hashimoto's encephalopathy. Am J Med Sci 1995;310(5):202-5.
21. Bostantjopoulou S, Zafiriou D, Katsarou Z, Kazis A. Hashimoto's encephalopathy: clinical and laboratory findings. Funct Neurol 1996;11:247-51.
22. Ghika-Schmid F, Ghika J, Regli F, et al. Hashimoto's myoclonic encephalopathy: an underdiagnosed treatable condition [comments]? Mov Disord 1996;11:555-62.
23. Kothbauer-Margreiter I, Sturzenegger M, Komor J, et al. Encephalopathy associated with Hashimoto thyroiditis: diagnosis and treatment. J Neurol 1996;243:585-93.
24. Bohnen NI, Parnell KJ, Harper CM. Reversible MRI findings in a patient with Hashimoto's encephalopathy. Neurology 1997;49:246-7.
25. Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 1997;49:623-6.
26. Maeda K, Tanimoto K. Epileptic seizures induces by thyrotropin releasing hormone. Lancet 1981;i:1058-9.
27. Henderson LM, Behan PO, Aarli J, et al. Hashimoto's encephalopathy: a new neuroimmunological syndrome. Ann Neurol 1987;22:140-1.
28. Mauriac L, Roger P, Kern AM, et al. Thyroidite de Hashimoto et encéphalopathie. Rev Franc Endocrinol Clin 1982;23:147-50.
29. Flynn SD, Nishiyama RH, Bigos ST. Autoimmune thyroid disease: immunological, pathological, and clinical aspects. Crit Rev Clin Lab Sci 1988;26:43-95.
30. Mariotti S, Ruf J, Caturegli P, et al. Methodological approach and diagnostic usefulness of a new assay for antithyroid peroxidase autoantibodies. Ann Biol Clin (Paris) 1989;47:541-5.
31. Mariotti S, Chiovato L, Vitti P, et al. Recent advances in the understanding of humoral and cellular mechanisms implicated in thyroid autoimmune disorders. Clin Immunol Immunopathol 1989;50:S73-84.
32. Jordan MW. Hashimoto's thyroiditis. J Am Osteopath Assoc 1967;66:1262-9.
33. Masters CL, Harris JO, Gajdusek DC, et al. Creutzfeldt-Jakob disease: patterns of worldwide occurrence and the significance of familial and sporadic clustering. Ann Neurol 1979;5:177-88.
34. Will RG. The spongiform encephalopathies [editorial]. J Neurol Neurosurg Psychiatry 1991;54:761-3.
35. Shibata N, Yamamoto Y, Sunami N, et al. Isolated angiitis of the CNS associated with Hashimoto's disease. Rinsho Shinkeigaku 1992;32:191-8.